Works by Huitema, Alwin D. R.


Results: 205
    1
    2
    3
    4
    5
    6

    Incidence and risk factors for nevirapine-associated rash.

    Published in:
    European Journal of Clinical Pharmacology, 2003, v. 59, n. 5/6, p. 457, doi. 10.1007/s00228-003-0613-3
    By:
    • de Maat, Monique M. R.;
    • ter Heine, Rob;
    • Mulder, Jan W.;
    • Meenhorst, Pieter L.;
    • Mairuhu, Albert T. A.;
    • van Gorp, Eric C. M.;
    • Huitema, Alwin D. R.;
    • Beijnen, Jos H.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia.

    Published in:
    PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0211910
    By:
    • Favié, Laurent M. A.;
    • Groenendaal, Floris;
    • van den Broek, Marcel P. H.;
    • Rademaker, Carin M. A.;
    • de Haan, Timo R.;
    • van Straaten, Henrica L. M.;
    • Dijk, Peter H.;
    • van Heijst, Arno;
    • Dudink, Jeroen;
    • Dijkman, Koen P.;
    • Rijken, Monique;
    • Zonnenberg, Inge A.;
    • Cools, Filip;
    • Zecic, Alexandra;
    • van der Lee, Johanna H.;
    • Nuytemans, Debbie H. G. M.;
    • van Bel, Frank;
    • Egberts, Toine C. G.;
    • Huitema, Alwin D. R.;
    • null, null
    Publication type:
    Article
    13
    14
    15

    Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry

    Published in:
    Rapid Communications in Mass Spectrometry: RCM, 2007, v. 21, n. 15, p. 2505, doi. 10.1002/rcm.3119
    By:
    • ter Heine, Rob;
    • Alderden-Los, Carolien G.;
    • Rosing, Hilde;
    • Hillebrand, Michel J. X.;
    • van Gorp, Eric C. M.;
    • Huitema, Alwin D. R.;
    • Beijnen, Jos H.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG.

    Published in:
    2007
    By:
    • Joerger, Markus;
    • Huitema, Alwin D. R.;
    • Richel, Dick J.;
    • Dittrich, Christian;
    • Pavlidis, Nikolas;
    • Briasoulis, Evangelos;
    • Vermorken, Jan B.;
    • Strocchi, Elena;
    • Martoni, Andrea;
    • Sorio, Roberto;
    • Sleeboom, Henk P.;
    • Izquierdo, Miguel A.;
    • Jodrell, Duncan I.;
    • Féty, Réegine;
    • de Bruijn, Ernst;
    • Hempel, Georg;
    • Karlsson, Mats;
    • Tranchand, Brigitte;
    • Schrijvers, Ad H. G. J.;
    • Twelves, Chris
    Publication type:
    journal article
    32
    33

    The Authors' Reply.

    Published in:
    Clinical Pharmacokinetics, 2006, v. 45, n. 2, p. 214, doi. 10.2165/00003088-200645020-00007
    By:
    • Huitema, Alwin D. R.;
    • Beijnen, Jos H.
    Publication type:
    Article
    34
    35

    The Authors’ Reply.

    Published in:
    Clinical Pharmacokinetics, 2005, v. 44, n. 4, p. 439
    By:
    • Kappelhoff, Bregt S.;
    • Huitema, Alwin D. R.;
    • Beijnen, Jos H.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42

    Pharmacokinetic exposure and treatment outcomes of lenvatinib in patients with renal cell carcinoma and differentiated thyroid carcinoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-024-04746-5
    By:
    • Meertens, Marinda;
    • Giraud, Eline L.;
    • Hassan, Esbar;
    • Zielhuis, Sybrand W.J.;
    • Snels, Tiemen T.;
    • Desar, Ingrid M. E.;
    • Walraven, Janneke E. W.;
    • Wilgenhof, Sofie;
    • van Thienen, Johannes V.;
    • de Boer, Jan Paul;
    • Steeghs, Neeltje;
    • van Erp, Nielka P.;
    • Huitema, Alwin D. R.
    Publication type:
    Article
    43
    44
    45

    Are novel oral oncolytics underdosed in obese patients?

    Published in:
    Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 2, p. 129, doi. 10.1007/s00280-023-04601-z
    By:
    • Lin, Lishi;
    • van der Meer, Ellen K. O.;
    • Steeghs, Neeltje;
    • Beijnen, Jos H.;
    • Huitema, Alwin D. R.
    Publication type:
    Article
    46

    Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 1, p. 33, doi. 10.1007/s00280-022-04489-1
    By:
    • de Rouw, Nikki;
    • Boosman, René J.;
    • Burgers, Jacobus A.;
    • Huitema, Alwin D. R.;
    • Dingemans, Anne-Marie C.;
    • Derijks, Hieronymus. J.;
    • Burger, David M.;
    • Piet, Berber;
    • Hendriks, Lizza E. L.;
    • Biesma, Bonne;
    • Pruis, Melinda A.;
    • Dumoulin, Daphne W.;
    • Croes, Sander;
    • Mathijssen, Ron H. J.;
    • van den Heuvel, Michel M.;
    • ter Heine, Rob
    Publication type:
    Article
    47
    48
    49
    50